[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pyxis Oncology Inc 321 HARRISON AVENUE BOSTON MA 02118 USA

www.pyxisoncology.com Employees: 56 P: 617-453-3596

Sector:

Medical

Description:

Pyxis Oncology Inc. is a preclinical oncology company. It focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers. The company's product pipeline includes antibody drug conjugate and monoclonal antibody. Pyxis Oncology Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 141,282
Enterprise Value, $K 124,392
Shares Outstanding, K 63,355
Float, K 59,744
% Float 94.30%
Short Interest, K 2,290
Short Float 3.61%
Days to Cover 1.25
Short Volume Ratio 0.47
% of Insider Shareholders 5.70%
% of Institutional Shareholders 39.07%

Financials:

Annual Sales, $ 13,860 K
Annual Net Income, $ -79,620 K
Last Quarter Sales, $ 11,040 K
Last Quarter Net Income, $ -18,110 K
EBIT, $ -82,030 K
EBITDA, $ -80,480 K

Growth:

1-Year Return 88.89%
3-Year Return -13.23%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 05/14/26
Next Earnings Date 08/13/26 [--]
Earnings Per Share ttm -1.29
EPS Growth vs. Prev Qtr -27.59%
EPS Growth vs. Prev Year -5.71%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PYXS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -135.60%
Return-on-Assets % -85.00%
Profit Margin % -574.46%
Debt/Equity 0.00
Price/Sales 11.11
Price/Cash Flow N/A
Price/Book 4.60
Book Value/Share 0.86
Interest Coverage -2.53
60-Month Beta 1.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.